Case report · 16 May 2022
Conference abstractPublished 14 Apr 2014
The current ECMO (VV and VA-ECMO)
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: ECMO has been utilized for refractory cardiac and respiratory failure. Its outcomes were almost dismal if it were not utilized appropriately. Since July of 2010, we have developed new ECMO program in our institution and our outcomes have improved remarkably. Objective: We would like to share the current ECMO system, including technology and patient care, to optimize patient outcomes. Methods: New ECMO program consisting of standard cannulation technique (groin venous and arterial access with retrograde perfusion catheter for VA-ECMO, Avalon dual lumen cannula for VV-ECMO), standard circuit (closed crystalloid primed circuit, heparin coated tubing and cannulae, diffusion membrane hollow-fiver oxygenator and Rota flow centrifugal pump), standard monitoring system (upper extremity arterial line, cerebral and lower extremity tissue saturation monitoring and hemodynamic transesophageal echocardiography), monitoring by multidisciplinary providers (ICU RN, mid-level providers and intensivists), and weaning using standard protocol with hemodynamic transesophageal echocardiography. Results: Since the beginning of new ECMO program, a total of 94 ECMO (76 VA and 18 VV ECMO) procedures were performed. The mean age was 48 ± 13, of 53 male and 41 female patients. There were 30 salvage cases (post code). The overall ECMO survival rate was 55% (VA ECMO 51%, and VV ECMO 70%), and discharged from hospital in alive in 45%. Conclusion: The outcomes of new ECMO program are reasonable. The expansion of the ECMO program is expected.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Mar 2022
Complications related to veno-arterial extracorporeal membrane oxygenation in patients with acute myocardial infarction: VA-ECMO complications in AMI
Conference abstract · 1 Jul 2019
The use of VA-ECMO in the cathlab: STEMI and High Risk Percutaneous Coronary Interventions
Conference abstract · 2019
The use of VA-ECMO in the cath lab: STEMI and high risk percutaneous coronary interventions
Editorial · 2019
The use of VA-ECMO in the cathlab STEMI and high risk percutaneous coronary interventions
More from this journal
The newest in Clinical and Experimental Cardiology.
Short communication · 4 Aug 2026
An effective determination method for aortic valve replacement through minimally invasive lower median sternotomy
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Hitoshi Hirose”

